Arrowhead Pharmaceuticals (ARWR) Selling, General & Administrative (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Selling, General & Administrative of $47.12 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 52.3% from $30.95 million a year earlier and up 12.9% from the prior quarter.
Arrowhead Pharmaceuticals (ARWR) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Arrowhead Pharmaceuticals was $172.57 million, up 53.2% year-over-year; for FY2025 (ended Sep 30, 2025), it was $123.94 million, up 25.5% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of 18.8% (FY2020 to FY2025).
- In prior fiscal years, Arrowhead Pharmaceuticals' Selling, General & Administrative was $98.76 million in FY2024 (+6.7%), $92.55 million in FY2023 (-25.6%), $124.43 million in FY2022 (+53.7%) and $80.98 million in FY2021 (+54.9%).
- The fiscal Q3 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to fiscal Q3 2010.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last eight quarters, with growth averaging 34.8% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was fiscal Q1 2022, with growth of 184.0%; the weakest was fiscal Q2 2023, with a decline of 32.2%.
- According to Business Quant data, Selling, General & Administrative for the three prior fiscal quarters was $41.74 million (Q2 2026), $46.02 million (Q1 2026) and $37.68 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Arrowhead Pharmaceuticals | 9.06 Bn | 3.84 Bn | - | 47.12 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.12 Mn |
| Mar 31, 2026 | 41.74 Mn |
| Dec 31, 2025 | 46.02 Mn |
| Sep 30, 2025 | 37.68 Mn |
| Jun 30, 2025 | 30.95 Mn |
| Mar 31, 2025 | 28.41 Mn |
| Dec 31, 2024 | 26.91 Mn |
| Sep 30, 2024 | 26.38 Mn |
| Jun 30, 2024 | 23.71 Mn |
| Mar 31, 2024 | 25.07 Mn |
| Dec 31, 2023 | 23.61 Mn |
| Sep 30, 2023 | 24.57 Mn |
| Jun 30, 2023 | 23.77 Mn |
| Mar 31, 2023 | 23.22 Mn |
| Dec 31, 2022 | 20.99 Mn |
| Sep 30, 2022 | 32.03 Mn |
| Jun 30, 2022 | 33.14 Mn |
| Mar 31, 2022 | 34.27 Mn |
| Dec 31, 2021 | 25.00 Mn |
| Sep 30, 2021 | 37.40 Mn |
Arrowhead Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();